InvestorsHub Logo
Followers 34
Posts 1545
Boards Moderated 0
Alias Born 01/21/2016

Re: None

Sunday, 10/27/2019 2:10:15 AM

Sunday, October 27, 2019 2:10:15 AM

Post# of 92671
Cannabinoid Biosciences aquiring Betta4U Brands 's SFIO venture.
According to SEC filings CBDZ has acquired controlling interest in Smokefree Innotec (SFIO) on Sept 6 2019.
https://www.sec.gov/Archives/edgar/data/1760319/000176031919000019/form1-u.htm


Cannabinoid Biosciences has a $50 mil IPO listed with Nasdaq and is currently controlling KDCE as an OTBB ticker.Controlling shares of KDCE were purchased Oct 21 2019 as filed with Sec.
https://www.nasdaq.com/market-activity/ipos/overview?dealId=1071426-88546
https://www.otcmarkets.com/filing/html?id=13699895&guid=P0gSUaoGobxro3h

As per news release of Sept 25 ,SFIO announces merger with Betta4U Brands Inc.
https://www.businesswire.com/news/home/20190925005087/en/

Recent filings and news reports indicate a deal has been done where CBDZ has added Betta4U Brands to its portfolio to market CBD infused water using Neo Water among others.

Betta4U Brands Inc recently acquired Neo Water and is now moving forward quickly with exciting new lines of flavored waters including a CBD infused line.
Since 2011, the brand has seen consistent growth and is carried in over 2,500 locations nationwide.The Neo Water company posted over $10 million in revenues at the time of its acquisition.The acquisition leads Betta4U's target of $100 million in annualized revenues from a growing and expanding portfolio of beverage companies to be acquired over the next 24 months.
https://www.prnewswire.com/news-releases/smokefree-innotec-incsfio-provides-shareholder-update-300945118.html


CBDZ is also seeking control interest in the discovery, development, and commercialization of novel drugs using different cannabis products —proprietary cannabinoid, cannabidiol, endocannabinoids, phytocannabinoids, and synthetic cannabinoid products. Its operating strategy is research and development pipeline acquisitions.
https://markets.businessinsider.com/news/stocks/cannabinoid-biosciences-cbdz-set-to-launch-its-crowdfunding-campaign-to-raise-50-million-on-august-12-2019-1028365335